Advertisement

Topics

Absence of integrin α3β1 promotes the progression of HER2-driven breast cancer in vivo

20:00 EDT 16 May 2019 | Breast Cancer Research

HER2-driven breast cancer is correlated with poor prognosis, especially during its later stages. Numerous studies have shown the importance of the integrin α3β1 during the initiation and progression of breast ...

Original Article: Absence of integrin α3β1 promotes the progression of HER2-driven breast cancer in vivo

NEXT ARTICLE

More From BioPortfolio on "Absence of integrin α3β1 promotes the progression of HER2-driven breast cancer in vivo"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...